KPIs & Operating Metrics(New)
Assets By SegmentBreakdown Of AssetsCapital Expenditure By SegmentContractual ObligationsCost Of Goods SoldDeferred RevenueEmployee StatisticsGross Margin %Gross Margin Annual %Gross ProfitGross Profit AnnualIncome Before Income Tax By RegionNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Margin By Segment %Operating Margin By Segment Annual %Operating Profit (Loss) By SegmentOperating Profit (Loss) By Segment AnnualOpex As A % Of Total Revenue %OPEX SegregationProperty And Equipment By GeographyProperty And Equipment, Net BreakdownRevenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Gross Profit (2016 - 2025)

Historic Gross Profit for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $345.2 million.

  • Bio-Rad Laboratories' Gross Profit rose 93.57% to $345.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year decrease of 282.83%. This contributed to the annual value of $1.3 billion for FY2025, which is 282.83% down from last year.
  • As of Q4 2025, Bio-Rad Laboratories' Gross Profit stood at $345.2 million, which was up 93.57% from $343.4 million recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Gross Profit ranged from a high of $436.5 million in Q3 2021 and a low of $306.0 million during Q1 2025
  • For the 5-year period, Bio-Rad Laboratories' Gross Profit averaged around $367.6 million, with its median value being $362.4 million (2023).
  • As far as peak fluctuations go, Bio-Rad Laboratories' Gross Profit soared by 3689.42% in 2021, and later plummeted by 1463.92% in 2022.
  • Bio-Rad Laboratories' Gross Profit (Quarter) stood at $399.9 million in 2021, then dropped by 0.7% to $397.1 million in 2022, then decreased by 7.76% to $366.3 million in 2023, then decreased by 6.63% to $342.0 million in 2024, then grew by 0.94% to $345.2 million in 2025.
  • Its last three reported values are $345.2 million in Q4 2025, $343.4 million for Q3 2025, and $345.3 million during Q2 2025.